p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of

Bernat Baeza-Raja1, Pura Muñoz-Cánoves

  • 1Center for Genomic Regulation, Program on Differentiation and Cancer, E-08003 Barcelona, Spain.

Insights

p38 MAPK and nuclear factor-kappaB (NF-kappaB) signaling pathways are crucial for skeletal muscle development. This study reveals NF-kappaB as a downstream effector of p38, highlighting their crosstalk and the role of IL-6 in myogenesis.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • p38 MAPK and NF-kappaB signaling pathways influence skeletal myogenesis.
  • The precise role of NF-kappaB in myoblast differentiation is debated.
  • p38 MAPK is a known promoter of myoblast differentiation.

Purpose of the Study:

  • To investigate the interplay between p38 MAPK and NF-kappaB during skeletal myogenesis.
  • To elucidate the downstream effectors of this signaling crosstalk.
  • To determine the role of Interleukin-6 (IL-6) in the context of p38 and NF-kappaB signaling in myogenesis.

Main Methods:

  • Utilized C2C12 myoblast cell line.
  • Analyzed p38 and NF-kappaB activation during proliferation and differentiation.
  • Assessed NF-kappaB activity in response to p38 activation.
  • Measured IkappaBalpha levels and NF-kappaB-DNA binding.
  • Quantified p65-NF-kappaB transactivating potential.
  • Investigated IL-6 expression and its impact on myogenesis via mRNA interference and overexpression.

Main Results:

  • p38 MAPK activation is specific to differentiating myocytes, while NF-kappaB is active throughout.
  • NF-kappaB activation is dependent on p38 activity during differentiation, with NF-kappaB acting as a p38 effector.
  • p38 activation enhances NF-kappaB activity by reducing IkappaBalpha and increasing p65-NF-kappaB transactivation.
  • IL-6 expression is upregulated in a p38- and NF-kappaB-dependent manner during myoblast differentiation.
  • Modulating IL-6 levels directly impacts myogenic differentiation extent, and IL-6 can rescue NF-kappaB inhibition effects.

Conclusions:

  • Established a novel crosstalk mechanism between p38 MAPK and NF-kappaB signaling in skeletal myogenesis.
  • Identified NF-kappaB as a downstream effector of p38 MAPK during myoblast differentiation.
  • Demonstrated that IL-6 is a key promyogenic effector downstream of the p38-NF-kappaB pathway.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...